Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 104
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Control of aging-associated neurodegeneration via hypothalamic extracellular vesicles containing parathymosin

Control of aging-associated neurodegeneration via hypot...

 63

Protein quality control machinery: regulators of condensate architecture and functionality

Protein quality control machinery: regulators of conden...

 88

Dysfunctional mitochondria trap proteins in the intermembrane space

Dysfunctional mitochondria trap proteins in the interme...

 99